A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes
- 1 January 2015
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in European Journal of Gastroenterology & Hepatology
- Vol. 27 (1), 1-7
- https://doi.org/10.1097/meg.0000000000000233
Abstract
Liver function tests (LFTs) are commonly performed to investigate asymptomatic individuals or those with nonspecific symptoms. Understanding the prevalence of mildly abnormal LFTs in the general population and the prevalence of liver disease following abnormal LFTs has important implications for the planning of care pathways and the provision of healthcare services. A systematic review of the literature on the prevalence of abnormal LFTs in the general population and their respective health outcomes was conducted. A total of 37 studies reporting data on the prevalence of abnormal LFTs (published between 2000 and 2014) were identified from online database searches or were manually selected from article bibliographies. The prevalence of mildly abnormal LFTs, with one or more abnormal constituents in the LFT, was high at 10-21.7%. The prevalence of severe liver disease within cohorts with abnormal LFTs is relatively low (<5%), and a large proportion of abnormal LFTs remains unexplained. Among individuals with unexplained abnormal LFTs, risk factors include obesity and insulin resistance. Common aetiologies for abnormal LFTs were non-alcohol-related fatty liver disease (NAFLD), followed by alcohol use and viral infections. In addition, normal LFTs do not rule out liver disease. The prevalence of abnormal LFTs depends on the definition and population but is likely to be between 10 and 20% in the general population. Abnormal LFTs are associated with a range of health outcomes but are not necessarily strongly diagnostic of severe liver pathology. Important areas of future research include further studies on the prevalence and predictive ability of LFTs in large, population-representative samples.Keywords
This publication has 56 references indexed in Scilit:
- What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective studyBMJ Open, 2013
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological AssociationHepatology, 2012
- When and how to evaluate mildly elevated liver enzymes in apparently healthy patientsCleveland Clinic Journal of Medicine, 2010
- Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)Health Technology Assessment, 2009
- High prevalence of abnormal alanine and aspartate aminotransferases in a “worried-well” population in the United Kingdom: Rationale for a liver screening program?Hepatology, 2008
- Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels: Suggestions for diagnostic procedures and monitoringDigestive and Liver Disease, 2008
- The Prevalence and Predictors of Elevated Serum Aminotransferase Activity in the United States in 1999-2002The American Journal of Gastroenterology, 2006
- Prevalence and etiology of altered liver tests: A population-based survey in a Mediterranean townHepatology, 2005
- Evaluation of abnormal liver function testsPublished by Oxford University Press (OUP) ,2003
- How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impactBMJ, 2001